A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results